Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tempus
AddedFeb 13, 2024
UpdatedJul 4, 2026
Tempus

Tempus

Late Stage Private

Chicago-based Tempus Labs, Inc. offers genomic sequencing and data analysis for real-time medical decisions in the US.

HQ
Chicago, IL, US
Founded
2015
Overview
Compare
Fundraising
Employees
News
Website

Founded in Chicago, Illinois, Tempus Labs, Inc. is a biotechnology company dedicated to transforming healthcare through the power of data and artificial intelligence. Their core mission is to provide genomic sequencing and data analysis to enable physicians to make real-time, data-driven medical decisions. Tempus offers services that include genomic sequencing and molecular data analysis, focusing primarily on oncology and other therapeutic areas within the United States.

Notable figures associated with Tempus Labs include its founder, Eric Lefkofsky, who is also known for co-founding Groupon. The company has attracted significant investment from high-profile venture capital firms and individual investors. Key achievements include partnerships with leading healthcare institutions and the development of AI-driven tools that have accelerated the discovery of novel therapeutic targets. Tempus Labs has made a substantial impact by integrating precision medicine into clinical practice, thereby improving patient outcomes through personalized treatment strategies.

Tempus - Products & Services

  • Genomic Profiling for Precision Oncology logo

    Genomic Profiling for Precision Oncology

    Tempus Labs applies AI to clinical and molecular data to enable precision medicine decisions in oncology.

    Competing Products

    Ataraxis AI logo
    Fuze Health logo

Tempus - Similar Companies

Ataraxis AI logo

Ataraxis AI

ataraxis.ai

Fuze Health logo

Fuze Health

fuzehealth.com

Genomenon logo

Genomenon

genomenon.com

Data Driven Bioscience logo

Data Driven Bioscience

Nest Genomics logo

Nest Genomics

nestgenomics.com

Gencove logo

Gencove

gencove.com

Ovation logo

Ovation

ovation.io

GenomOncology logo

GenomOncology

genomoncology.com

Sequencing.com logo

Sequencing.com

sequencing.com

Dnanexus logo

Dnanexus

dnanexus.com

WhiteLab Genomics logo

WhiteLab Genomics

whitelabgx.com

Singular Genomics logo

Singular Genomics

Foundation Medicine logo

Foundation Medicine

Navipoint Genomics logo

Navipoint Genomics

Owkin logo

Owkin

owkin.com

Tempus - Quick Facts

Who are Tempus' competitors?

Companies similar to Tempus include Ataraxis AI, Fuze Health, Genomenon and Data Driven Bioscience.

When was Tempus founded?

Tempus was founded in 2015.

Where is Tempus' headquarters located?

Tempus' headquarters is located in Chicago, IL, US.

When was Tempus' last funding round?

Tempus' most recent funding round was for $100M (USD) in October 2022.

How much has Tempus raised to-date?

As of Oct 20, 2022, Tempus has raised a total of $1.3B (USD).

How many employees does Tempus have?

Tempus has 2,421 employees as of Feb 5, 2024.

Tempus - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Software
Tags
  • Biotech
  • Healthtech
Unique IDs
  • secCik: 0001717115
  • ticker: TEM
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
Show 17 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 6000Depository Institutions
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research